Penumbra, Inc. (PEN)
340.16
-2.14
(-0.63%)
USD |
NYSE |
Mar 03, 16:00
340.29
+0.13
(+0.04%)
After-Hours: 20:00
Penumbra Research and Development Expense (TTM) : 83.18M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Globus Medical, Inc. | 146.94M |
| iRhythm Holdings, Inc. | 84.61M |
| Rapt Therapeutics, Inc. | 82.87M |